$RGBP

New Post Public Reply Private Reply Replies (0) Message Board
//Desmond//
$RGBP NEWS

http://www.prnewswire.com/news-releases/regen...39361.html

Regen BioPharma Submits Application to FDA for Orphan Drug Designation for its HemaXellerate Product

PR Newswire

SAN DIEGO, January 26, 2016


SAN DIEGO, January 26, 2016 /PRNewswire/ --

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today submission to the Food and Drug Administration (FDA) of an application requesting Orphan Drug status for the use of HemaXellerate for the treatment of aplastic anemia.

"Because HemaXellerate is a personalized cell therapy product aimed at addressing an unmet medical need, we are hopeful that the FDA will grant it orphan status," said David Koos, Ph.D., Chairman and CEO of Regen BioPharma.

HemaXellerate is comprised of cells extracted from the patient's own fat tissue and processed using a proprietary method so as to induce a biological response in the patient that heals damaged bone marrow and restores ability of the body to generate healthy blood cells. The FDA recently cleared Regen to perform phase I clinical trials using HemaXellerate in aplastic anemia patients.

Having an Orphan Drug designation for HemaXellerate is important as it will allow for:
•Annual grant funding to defray the cost of clinical testing
•Tax credits for the costs of clinical research
•Assistance in clinical research study design
•Seven-year period of exclusive marketing after an orphan drug is approved
•Waiver of Prescription Drug User Fee Act (PDUFA) filing fees

"Should HemaXellerate be fortunate enough to be designated an Orphan Drug, we will take advantage of the rich resources the National Institutes of Health provides in assisting development of such drugs to get HemaXellerate to market as quickly as possible," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma.

About Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Regen BioPharma Inc.

David R. Koos, PhD
Chairman & Chief Executive Officer
+1-619-702-1404 Phone
+1-619-330-2328 Fax
David.koos@regenbiopharma.com

The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com

http://www.regenbiopharma.com
http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com

Twitter: Regen BioPharma News: https://twitter.com/KoosRegen


SOURCE Regen BioPharma Inc.

Trade and Invest for Your Retirement All in One Place with E*TRADE.

Regen BioPharma Inc (RGBPD) Stock Research Links

RGBPD Board Company Profile Buy Rating Time & Sales News Filings Financials
All of my posts are honest, opinion based statements from due diligence performed by myself.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 2

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 2

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 0

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 1

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 4

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
LG's High-Purity RGB Displays Shine at IFA 2026

Updated Category News Views 3

LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...

Continue Reading
Plumbing Pitfalls: When Water Heater Noises Spell Trouble

Updated Category News Views 5

Understanding the Clamor from Your Water Heater The hustle and bustle of everyday life often drown out the less important noises. But when your water heater starts making a ruckus, maybe it's time to listen. From the keen ears of Jared Voss, a plumbing expert with his roots dug deep in Clinton, Iowa, we get the lowdown on what these noises could mean for your plumbing....

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

Updated Category News Views 2

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nate Silver Analyzes Kamala Harris's Chances in Florida Race

Updated Category News Views 110

Analyzing Kamala Harris's Prospects in Florida The 2024 presidential election landscape is shifting, and veteran pollster Nate Silver has provided insight into whether Vice President and Democratic candidate Kamala Harris should focus her campaign efforts on Florida, a traditionally Republican stronghold. Florida's Changing Political Climate Once deemed a critical swing...

Continue Reading
Celebree School Expands Early Education Impact in Community

Updated Category News Views 125

Exciting News from Celebree School Celebree School is thrilled to announce the opening of its newest location in a vibrant community, dedicated to providing exceptional early childhood education. The school will offer various programs tailored for infants, toddlers, and preschool-age children, focused on their physical, social, emotional, and academic development. A...

Continue Reading
Cheetah Net Supply Chain's Third Quarter Review and Insights

Updated Category News Views 249

Cheetah Net Supply Chain Service Inc. Announces Q3 2025 Results Cheetah Net Supply Chain Service Inc. (NASDAQ: CTNT), a key player in warehousing and logistics, has shared its financial results for the third quarter of 2025. With the company navigating through a challenging landscape, let’s explore the details surrounding its latest performance. Financial Highlights...

Continue Reading
Palantir's Remarkable Quarter and Future Growth Dynamics

Updated Category News Views 211

Palantir's Quarterly Performance Highlights Palantir Technologies (NASDAQ: PLTR) has made headlines recently as it announced exceptional quarterly results that underline the increasing demand for AI technologies. The latest financial report not only emphasizes the strong performance of the company but also raises significant questions about the future of AI valuations in...

Continue Reading
Stifel's Hold Rating on Air Canada Amid Growth Strategies

Updated Category News Views 74

Stifel Initiates Coverage on Air Canada Stifel Canada has begun its coverage of Air Canada (AC:CN) (OTC: ACDVF) with a Hold rating and set a price target of C$20.00. This strategic rating reflects the airline's current efforts to rebuild in the aftermath of the COVID-19 pandemic. The analysis reveals that Air Canada is approaching a critical juncture, buoyed by favorable...

Continue Reading